Back to top

Erasca announces IND clearance for ERAS-4001

Erasca (ERAS) announced clearance of an investigational new drug application by the FDA for ERAS-4001, a potential first-in-class and best-in-class...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Erasca, Inc. (ERAS)